Filing Details

Accession Number:
0001415889-24-008322
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-18 17:46:10
Reporting Period:
2023-01-09
Accepted Time:
2024-03-18 17:46:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650131 Peter Radovich C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-09 1,379 $20.62 33,316 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.